Home / Stocks / ENNATURE
Back to all stocks
NSE · ENNATURE

Ennature Bio Pharma Limited (ENNATURE) Share Price

Sector: Healthcare · ISIN: INE2WCT01016

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,017
of 5,047 stocks
▼ 1311W
Peak #1,886 · 08 Nov 2026

Ennature Bio Pharma Limited, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and has promoters holding 60%. Ownership as of Nov 2026.

Market Cap
443.38 Cr
P/E Ratio
90.62
P/B Ratio
0.83
ROE
0.92%
ROCE
1.11%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27
Revenue78.46 Cr
Net Profit4.89 Cr
EPS2.19
Operating Profit6.64 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
59.63%
Public
40.37%

As of 03 Nov 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹6.30
Cr total
5
Schemes
5
Fund Houses
₹6.30 Cr
Total Exposure
Motilal Oswal Mutual Fund₹2.59 Cr (41.0%)
Groww Mutual Fund₹0.02 Cr (0.3%)
Mirae Asset Mutual Fund₹0.00 Cr (0.0%)
Bandhan Mutual Fund₹0.00 Cr (0.0%)
SchemeFund HouseValue (Cr)%

Top 5 MF holders by market value as of 01 Oct 2026.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs